-
1دورية أكاديمية
المؤلفون: Gajanan A Pise, Naveen Manohar, Shruthi S Prasad, Shilpika Thakur
المصدر: Indian Dermatology Online Journal, Vol 15, Iss 2, Pp 324-325 (2024)
مصطلحات موضوعية: Dermatology, RL1-803
وصف الملف: electronic resource
-
2
المؤلفون: Luis A. Marín-Castañeda, Jonathan Matías Chejfec-Ciociano, Véronique Verhoeven, Christian Baumgartner, Nino Fijačko, Gregor Štiglic, Lucija Gosak, Mohamed M. Arnaout, Naveen Manohar, Shruthi S. Prasad, Kaushik Bhattacharya, William C. Cho, Takanobu Hirosawa, Ángel Lee
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ddfe8a6107cd738167d9e4b1c4719d5c
https://doi.org/10.2196/preprints.49419 -
3
المؤلفون: Pratibha J P, Shruthi S Prasad, Naveen Manohar
المصدر: Cureus.
مصطلحات موضوعية: General Engineering
-
4
المؤلفون: Naveen Manohar, Shruthi S Prasad
المصدر: Cureus.
مصطلحات موضوعية: General Engineering
-
5
المؤلفون: Rupal M Oswal, Shruthi S Prasad, Naveen Manohar, Gajanan A Pise, Kiran Rao
المصدر: Cureus.
مصطلحات موضوعية: General Engineering
-
6دورية أكاديميةA Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.
المؤلفون: Kebir S; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, Essen, Germany.; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany., Ullrich V; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany., Berger P; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Dobersalske C; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Langer S; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany., Rauschenbach L; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.; Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany., Trageser D; Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty & University Hospital Bonn, Bonn, Germany.; LIFE & BRAIN GmbH, Cellomics Unit, Bonn, Germany., Till A; Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty & University Hospital Bonn, Bonn, Germany., Lorbeer FK; Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty & University Hospital Bonn, Bonn, Germany., Wieland A; Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty & University Hospital Bonn, Bonn, Germany., Wilhelm-Buchstab T; Department of Radiology, University of Bonn Medical Center, Bonn, Germany., Ahmad A; Bonn-Aachen International Center for IT (B-IT), University of Bonn, Bonn, Germany., Fröhlich H; Bonn-Aachen International Center for IT (B-IT), University of Bonn, Bonn, Germany.; Department of Bioinformatics, Fraunhofer SCAI, Schloss Birlinghoven, Sankt Augustin, Germany., Cima I; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany., Prasad S; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Matschke J; Institute of Cell Biology (Cancer Research), University Hospital Essen, Essen, Germany., Jendrossek V; Institute of Cell Biology (Cancer Research), University Hospital Essen, Essen, Germany., Remke M; German Cancer Consortium (DKTK).; Pediatric Neuro-Oncogenomics, University Hospital Düsseldorf, Düsseldorf, Germany., Grüner BM; German Cancer Consortium (DKTK).; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany., Roesch A; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.; Department of Dermatology, University Hospital Essen, Essen, Germany., Siveke JT; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.; Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK, Partner Site Essen) and German Cancer Research Center, DKFZ, Heidelberg, Germany., Herold-Mende C; Division of Neurosurgical Research, Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany., Blau T; Institute of Neuropathology, University of Duisburg-Essen, Essen, Germany., Keyvani K; Institute of Neuropathology, University of Duisburg-Essen, Essen, Germany., van Landeghem FKH; Institute of Neuropathology, University of Bonn, Bonn, Germany., Pietsch T; Institute of Neuropathology, University of Bonn, Bonn, Germany., Felsberg J; Institute of Neuropathology, Heinrich Heine University, Düsseldorf, Germany., Reifenberger G; German Cancer Consortium (DKTK).; Institute of Neuropathology, Heinrich Heine University, Düsseldorf, Germany., Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Sure U; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.; Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany., Brüstle O; Institute of Reconstructive Neurobiology, University of Bonn Medical Faculty & University Hospital Bonn, Bonn, Germany.; LIFE & BRAIN GmbH, Cellomics Unit, Bonn, Germany., Simon M; Department of Neurosurgery, University of Bonn Medical Center, Bonn, Germany.; Department of Neurosurgery, Bethel Clinic, University of Bielefeld Medical Center, OWL, Bielefeld, Germany., Glas M; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, Essen, Germany.; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany., Scheffler B; DKFZ-Division Translational Neurooncology at the WTZ, DKTK Partner Site, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK).; West German Cancer Center (WTZ), University Hospital Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center of Medical Biotechnology (ZMB), University Duisburg-Essen, Essen, Germany.
المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jan 17; Vol. 29 (2), pp. 488-500.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Glioblastoma*/drug therapy , Glioblastoma*/genetics , Glioblastoma*/pathology , Brain Neoplasms*/drug therapy , Brain Neoplasms*/genetics , Brain Neoplasms*/pathology, Humans ; Proto-Oncogene Proteins c-akt ; Drug Resistance, Neoplasm/genetics ; Temozolomide ; Cell Line, Tumor ; Xenograft Model Antitumor Assays ; Antineoplastic Agents, Alkylating/pharmacology ; Antineoplastic Agents, Alkylating/therapeutic use
-
7دورية أكاديمية
المؤلفون: Lu IN; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany., Dobersalske C; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany., Rauschenbach L; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany.; Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany., Teuber-Hanselmann S; Institute of Neuropathology, University Hospital Essen, Essen, Germany., Steinbach A; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany., Ullrich V; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany., Prasad S; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany., Blau T; Institute of Neuropathology, University Hospital Essen, Essen, Germany., Kebir S; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany.; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, Essen, Germany., Siveke JT; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany.; Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Hospital Essen, Essen, Germany.; DKFZ-Division of Solid Tumor Translational Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany., Becker JC; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany.; Translational Skin Cancer Research (TSCR), Department of Dermatology, University Medicine Essen, Essen, Germany., Sure U; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany.; Department of Neurosurgery and Spine Surgery, University Hospital Essen, Essen, Germany., Glas M; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany.; Division of Clinical Neurooncology, Department of Neurology, University Hospital Essen, Essen, Germany., Scheffler B; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany.; Center of Medical Biotechnology (ZMB), University of Duisburg-Essen, Essen, Germany., Cima I; DKFZ-Division Translational Neurooncology at the West German Cancer Center (WTZ), University Hospital Essen/University of Duisburg-Essen, Essen, Germany. i.cima@dkfz.de.; German Cancer Research Center (DKFZ), Heidelberg, Germany. i.cima@dkfz.de.; German Cancer Consortium (DKTK), Partner site Essen/Düsseldorf, Germany. i.cima@dkfz.de.
المصدر: Nature communications [Nat Commun] 2021 Jun 23; Vol. 12 (1), pp. 3895. Date of Electronic Publication: 2021 Jun 23.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
مواضيع طبية MeSH: Brain Neoplasms/*genetics , Glioblastoma/*genetics , Hematopoietic Stem Cells/*metabolism , Neoplastic Stem Cells/*metabolism, Brain Neoplasms/metabolism ; Brain Neoplasms/pathology ; Cell Line, Tumor ; Cell Proliferation/genetics ; Cells, Cultured ; Disease Progression ; Gene Expression Profiling/methods ; Gene Expression Regulation, Neoplastic ; Glioblastoma/metabolism ; Glioblastoma/pathology ; Humans ; Kaplan-Meier Estimate ; RNA-Seq/methods ; Signal Transduction/genetics ; Single-Cell Analysis/methods ; Tumor Microenvironment/genetics
-
8دورية أكاديمية
المؤلفون: Preillon J; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Cuende J; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Rabolli V; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Garnero L; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Mercier M; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Wald N; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Pappalardo A; ImmunoConcEpT, UMR 5164, Bordeaux University, CNRS, Bordeaux, France., Denies S; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Jamart D; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Michaux AC; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Pirson R; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Pitard V; ImmunoConcEpT, UMR 5164, Bordeaux University, CNRS, Bordeaux, France., Bagot M; INSERM U976, Université de Paris, Hôpital Saint Louis, Paris, France., Prasad S; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Houthuys E; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Brouwer M; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Marillier R; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Lambolez F; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Marchante JR; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Nyawouame F; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Carter MJ; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Southampton University Faculty of Medicine, Southampton, United Kingdom., Baron-Bodo V; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts., Marie-Cardine A; INSERM U976, Université de Paris, Hôpital Saint Louis, Paris, France., Cragg M; Antibody & Vaccine Group, Centre for Cancer Immunology, Cancer Sciences Unit, Southampton University Faculty of Medicine, Southampton, United Kingdom., Déchanet-Merville J; ImmunoConcEpT, UMR 5164, Bordeaux University, CNRS, Bordeaux, France.; Team labeled LIGUE 2017., Driessens G; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts. gregory.driessens@iteostherapeutics.com., Hoofd C; iTeos Therapeutics, Gosselies, Belgium and Cambridge, Massachusetts.
المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Jan; Vol. 20 (1), pp. 121-131. Date of Electronic Publication: 2020 Dec 04.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
مواضيع طبية MeSH: Cytotoxicity, Immunologic*/drug effects, Antibodies, Neoplasm/*immunology , Antibodies, Neoplasm/*pharmacology , Receptors, Immunologic/*antagonists & inhibitors , T-Lymphocytes, Regulatory/*immunology, Animals ; Antibodies, Monoclonal/immunology ; Antibody-Dependent Cell Cytotoxicity/drug effects ; Antigens, CD/metabolism ; Female ; Healthy Volunteers ; Humans ; Immunoglobulin G/metabolism ; Lymphocyte Depletion ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/immunology ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Receptors, Antigen, T-Cell, gamma-delta/metabolism ; Receptors, IgG/metabolism ; Receptors, Immunologic/metabolism ; T-Lymphocytes, Regulatory/drug effects ; Mice
-
9دورية أكاديمية
المؤلفون: Hettich M; Department of Radiation Oncology, Medical Center-University of Freiburg, Freiburg, Germany. Faculty of Biology, University of Freiburg, Freiburg, Germany., Lahoti J; Department of Radiation Oncology, Medical Center-University of Freiburg, Freiburg, Germany. Faculty of Biology, University of Freiburg, Freiburg, Germany. German Cancer Consortium (DKTK), Freiburg, Germany. German Cancer Research Center (DKFZ), Heidelberg, Germany., Prasad S; Department of Radiation Oncology, Medical Center-University of Freiburg, Freiburg, Germany. Faculty of Biology, University of Freiburg, Freiburg, Germany., Niedermann G; Department of Radiation Oncology, Medical Center-University of Freiburg, Freiburg, Germany. German Cancer Consortium (DKTK), Freiburg, Germany. German Cancer Research Center (DKFZ), Heidelberg, Germany. gabriele.niedermann@uniklinik-freiburg.de.
المصدر: Cancer research [Cancer Res] 2016 Aug 15; Vol. 76 (16), pp. 4673-83. Date of Electronic Publication: 2016 Jun 14.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Bispecific/*administration & dosage , Antineoplastic Agents/*administration & dosage , CD8-Positive T-Lymphocytes/*drug effects , Lymphocytes, Tumor-Infiltrating/*drug effects , Melanoma, Experimental/*pathology, Animals ; Antibodies, Bispecific/adverse effects ; Antineoplastic Agents/adverse effects ; CD8-Positive T-Lymphocytes/radiation effects ; Chemoradiotherapy/methods ; Flow Cytometry ; Lymphocytes, Tumor-Infiltrating/radiation effects ; Mice ; Mice, Inbred C57BL ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Radiotherapy
-
10دورية أكاديمية
المؤلفون: Prasad S; Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany. Faculty of Biology, University of Freiburg, Freiburg, Germany., Gaedicke S; Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany., Machein M; Department of Neurosurgery, University Hospital Freiburg, Freiburg, Germany., Mittler G; Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany., Braun F; Faculty of Biology, University of Freiburg, Freiburg, Germany. Department of Nuclear Medicine, University Hospital Freiburg, Freiburg, Germany., Hettich M; Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany. Faculty of Biology, University of Freiburg, Freiburg, Germany., Firat E; Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany., Klingner K; Oncotest GmbH, Freiburg, Germany., Schüler J; Oncotest GmbH, Freiburg, Germany., Wider D; Department of Hematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg, Germany., Wäsch RM; Department of Hematology, Oncology and Stem Cell Transplantation, University Hospital Freiburg, Freiburg, Germany., Herold-Mende C; Department of Neurosurgery, University of Heidelberg, Heidelberg, Germany., Elsässer-Beile U; Department of Urology, University Hospital Freiburg, Freiburg, Germany., Niedermann G; Department of Radiation Oncology, University Hospital Freiburg, Freiburg, Germany. German Cancer Consortium (DKTK), Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany. gabriele.niedermann@uniklinik-freiburg.de.
المصدر: Cancer research [Cancer Res] 2015 Jun 01; Vol. 75 (11), pp. 2166-76. Date of Electronic Publication: 2015 Apr 03.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE
مواضيع طبية MeSH: Antibodies, Bispecific/*therapeutic use , Antigens, CD/*immunology , Glioblastoma/*therapy , Glycoproteins/*immunology , Neoplastic Stem Cells/*immunology , Peptides/*immunology, AC133 Antigen ; Antibodies, Bispecific/immunology ; Antigens, CD/therapeutic use ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Carcinogenesis/immunology ; Cell- and Tissue-Based Therapy/methods ; Epitopes/immunology ; Glioblastoma/immunology ; Glioblastoma/pathology ; Glycoproteins/therapeutic use ; Humans ; Immunotherapy/methods ; Neoplastic Stem Cells/pathology ; Peptides/therapeutic use
Full Text Finder 
Find this article in full text from Springer Verlag.